Accendra Health ACH 深 沪
等待开盘 05-18 09:30:00 美东时间
2.91
-0.130
-4.28%
华盛通- 最 高3.175
- 今 开2.97
- 成交量 81.86万股
- 最 低 2.90
- 昨 收 3.04
- 总市值 2.23亿
- 52周最高 9.55
- 市盈率 静 --
- 换手率 1.07%
- 52周最低 1.84
- 委 比 -61.17%
- 总股本 7658.37万
- 历史最高 49.1525
- 量 比 0.49
- 振 幅 9.05%
- 历史最低 1.84
- 每 手 1
- 风险率 2.09%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Accendra Health shareholders approve amended 2023 omnibus incentive plan at annual meeting
Accendra Health shareholders approve amended 2023 omnibus incentive plan at annual meeting Accendra Health held its annual shareholder meeting on May 14, 2026. Shareholders backed a slate of six director nominees for one-year terms. KPMG LLP was ratified as independent registered public accounting f
05-15 20:32
美股大行评级 | 富国银行上调英伟达目标价从265美元升至315美元；Alamar、AEVEX获多家大行首予“买入”评级
今日重点评级关注：Needham：维持Artiva Biotherapeutics"买入"评级，目标价从18美元升至41美元；HC Wainwright & Co.：维持SAB Biotherapeutics"买入"评级，目标价从7美元升至10美元
05-13 11:46
Baird Maintains Outperform on Accendra Health, Raises Price Target to $6
Baird analyst Eric Coldwell maintains Accendra Health (NYSE:ACH) with a Outperform and raises the price target from $5 to $6.
05-12 19:32
Accendra推出资产负债表优化，去杠杆1.15亿美元并延长期限至2032-2033年
Accendra Health周一宣布启动一项全面的资产负债表优化交易，预计将减少至多1.15亿美元债务，同时将债务期限大幅延长至2032年和2033年。该...
05-12 03:34
Accendra Health Affirms FY2026 Sales Guidance of $2.550B-$2.650B vs $2.590B Est
Accendra Health (NYSE:ACH) affirms FY2026 sales outlook from $2.550 billion-$2.650 billion to $2.550 billion-$2.650 billion vs $2.590 billion estimate.
05-11 21:54
Accendra Health Announces Comprehensive Capital Structure Transaction
The latest update is out from Accendra Health ( ($ACH) ). On May 11, 2026, Acce...
05-11 19:18
Earnings Scheduled For May 11, 2026
Companies Reporting Before The Bell • United Parks & Resorts (NYSE:PRKS) is...
05-11 19:11
Accendra Health Q1 revenue falls, misses estimates
Accendra Health Q1 revenue falls, misses estimates Overview U.S. home-based care provider's Q1 revenue declined and missed analyst expectations Adjusted EPS and adjusted EBITDA for Q1 both beat analyst expectations Company announced $1.5 bln balance sheet optimization transaction to reduce leverage
05-11 18:38
Accendra Q1 FY26 net loss widens to $6.5 million; net revenue falls to $627.8 million
Accendra Q1 FY26 net loss widens to $6.5 million; net revenue falls to $627.8 million Accendra Health posted a GAAP net loss from continuing operations of USD 6.47 million, or USD 0.08 per share, as net revenue fell to USD 627.8 million. Adjusted EBITDA dropped to USD 58.4 million, while free cash f
05-11 18:32
美股大行评级 | 潜在涨幅214.14%！HC Wainwright & Co.：Ardelyx获机构升目标价至18美元，维持"买入"评级
今日重点评级关注：HC Wainwright & Co.：维持Ardelyx"买入"评级，目标价从10美元升至18美元；Truist Securities：维持Praxis Precision Medicine"买入"评级，目标价从500美元升至700美元
02-23 08:56
